HHS initiates a major reorganization
A major HHS reorganization directly impacts agencies and individuals that oversee federal programs relevant to allergists and our patients.
An interview with Congressman Bob Onder, MD – part 2
Drs. Miller and Meadows ask questions specifically focused on allergy/immunology practice and advocacy for the specialty.
2025 call for State Delegates
The success of our HOD depends on having adequate representation across the country. Are you ready to join us?
Is your practice compliant with HHS discrimination prohibitions?
Last year, the HHS Office for Civil Rights (OCR) issued a final rule implementing Section 1557 of the Affordable Care Act.
AMA Physician Practice Information survey results – explained
Unfortunately, the results of the AMA survey were not favorable to allergy/immunology, which has historically had very high practice expense.
The College is knocking on United Healthcare’s door
We are hopeful these letters will open a line of communication with UHC and educate them on the benefits and value of allergen immunotherapy.
Traditional MIPS or MVP for allergists in 2025?
This article provides an overview of current MVP reporting options and considerations for allergists.
Understanding the 340B program
The College’s Advocacy Council wants to ensure that allergists understand the program and how it can impact their practices.
College stands against NIH budget cuts
The College has taken a strong stand against proposed cuts to funding that would cap indirect costs for NIH research grants at 15%.
Northeast MAC changes policy regarding dilutions
The Northeast Region – National Government Services – has agreed to reimburse allergists for allergen extract dilutions.
… results in Advocacy Insider.
